CBDBY Statistics
Total Valuation
CBDBY has a market cap or net worth of $228.95 million. The enterprise value is $1.33 billion.
| Market Cap | 228.95M |
| Enterprise Value | 1.33B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| Forward PS | n/a |
| PB Ratio | 0.11 |
| P/FCF Ratio | 0.46 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.73, with an EV/FCF ratio of 2.66.
| EV / Earnings | n/a |
| EV / Sales | 0.41 |
| EV / EBITDA | 3.73 |
| EV / EBIT | 60.97 |
| EV / FCF | 2.66 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.61 |
| Quick Ratio | 0.29 |
| Debt / Equity | 0.87 |
| Debt / EBITDA | 4.94 |
| Debt / FCF | 3.52 |
| Interest Coverage | 0.17 |
Financial Efficiency
Return on equity (ROE) is -1.40% and return on invested capital (ROIC) is -1.67%.
| Return on Equity (ROE) | -1.40% |
| Return on Assets (ROA) | -0.40% |
| Return on Capital (ROIC) | -1.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.37 |
| Inventory Turnover | 3.27 |
Taxes
| Income Tax | -79.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.59% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -89.59% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 0.65 |
| Relative Strength Index (RSI) | 32.73 |
| Average Volume (20 Days) | 61,470 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CBDBY had revenue of $3.27 billion and -$32.51 million in losses. Loss per share was -$0.11.
| Revenue | 3.27B |
| Gross Profit | 757.75M |
| Operating Income | -63.41M |
| Pretax Income | -110.26M |
| Net Income | -32.51M |
| EBITDA | 356.86M |
| EBIT | 21.84M |
| Loss Per Share | -$0.11 |
Balance Sheet
The company has $660.70 million in cash and $1.76 billion in debt, giving a net cash position of -$1.10 billion.
| Cash & Cash Equivalents | 660.70M |
| Total Debt | 1.76B |
| Net Cash | -1.10B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.02B |
| Book Value Per Share | n/a |
| Working Capital | 1.90B |
Cash Flow
In the last 12 months, operating cash flow was -$38.05 million and capital expenditures $539.34 million, giving a free cash flow of $501.29 million.
| Operating Cash Flow | -38.05M |
| Capital Expenditures | 539.34M |
| Free Cash Flow | 501.29M |
| FCF Per Share | $1.86 |
Margins
Gross margin is 23.14%, with operating and profit margins of -1.94% and -0.99%.
| Gross Margin | 23.14% |
| Operating Margin | -1.94% |
| Pretax Margin | -3.37% |
| Profit Margin | -0.99% |
| EBITDA Margin | 10.90% |
| EBIT Margin | 0.67% |
| FCF Margin | 15.31% |
Dividends & Yields
CBDBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.38% |
| Earnings Yield | -14.20% |
| FCF Yield | 218.95% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | 10.92% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CBDBY has an Altman Z-Score of 0.99 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.99 |
| Piotroski F-Score | 2 |